You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
9 July 2026 - Northwest Biotherapeutics (OTCQB:NWBO)(NWBio), a biotechnology company developing DCVax personalised immune therapies for solid tumour cancers, announced on Wednesday that the company's chief technical officer, Dr. Marnix Bosch, pr...
9 July 2026 - Lynk Pharmaceuticals Co Ltd, a clinical-stage innovative drug development company focused on immune and inflammatory diseases, announced on Wednesday that the first patient has been successfully dosed in the Phase II clinical trial eval...
9 July 2026 - Taiwan-listed clinical-stage biotech HanchorBio Inc (TWSE:7827) announced on Wednesday that it is looking to broaden the development path for HCB101, its lead oncology asset, through a new partnership.HanchorBio's subsidiary, FBD B...
8 July 2026 - Healthcare solutions provider GE HealthCare Technologies Inc (NASDAQ: GEHC) and non-profit organisation Mayo Clinic announced on Wednesday the launch of the MI-BET (Molecular Imaging Biomarker-Based End of Therapy Trial) research collab...
8 July 2026 - Clinical-stage biotechnology company Insilico Medicine (HKEX:3696) announced on Tuesday the initiation of the Phase III clinical trial for Rentosertib, its potentially first-in-class oral small-molecule inhibitor targeting TNIK for the ...
8 July 2026 - Biotechnology company Aptamer Group plc (AIM: APTA) announced on Wednesday that it has commenced development of Optimer binders for a potential rapid diagnostic test targeting the Bundibugyo strain of Ebola virus, addressing a critical ...
8 July 2026 - Physiomics plc (AIM: PYC), a mathematical modelling, data science and biostatistics company, declared on Wednesday that it has secured multiple contract awards with a combined estimated value exceeding GBP200,000, covering its Biometric...